Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Cash Flow Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.47M -1.21M -1.53M 12.88M -735.18K -2.86M -2.62M -2.68M -2.41M -3.65M -4.11M -7.22M -5.82M -4.42M -3.6M -4.69M -2.64M
Depreciation & Amortization
2.12K 23.8K 53.58K 112.38K 2.94K 79.39K 75.38K 75.41K 75.78K 75.65K 77.32K 83.35K 86.83K 82.97K 87.74K 88.26K 88.64K
Stock-Based Compensation
n/a 31.26K 38.45K 47.23K 386.03K 389.21K 483.46K 490.6K 431.2K 684.77K 898K 659.26K 1.44M 274.33K 381.06K 336.85K 186.1K
Other Working Capital
2.43K n/a 31.8K -1.89M -294.53K 1.51M -222.49K -752.85K -625.89K -266K 517.68K 551.18K -393.11K 897.91K 578.81K -2.43M 285.33K
Other Non-Cash Items
889.46K 603.95K 859.74K -13.39M -2.88M 572.05K -37.53K 138.56K -19.82K 204.57K -109.94K 62.13K 47.37K 201.16K 45.33K 293.1K -494.64K
Deferred Income Tax
n/a n/a n/a n/a n/a -389.21K -5.27K -9.15K n/a n/a n/a n/a n/a -11.54K 38.85K 12.02K -189.92K
Change in Working Capital
-17.42K 523.16K 131.72K -2.36M 562.85K 1.58M -151.1K -778.09K -439.43K -385.2K 551.78K 586.24K -595.15K 932.16K 506.22K -2.48M 280.54K
Operating Cash Flow
-598.71K -23.56K -398.58K -2.76M -2.19M -623.02K -2.25M -2.76M -2.36M -3.07M -2.69M -5.83M -4.84M -2.94M -2.54M -6.45M -2.77M
Capital Expenditures
n/a n/a -1.27K n/a n/a -1.21K -678 -2.49K -2.47K n/a -580 n/a n/a -24.49K -1.67K -2.23K -3.16K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a -8 3.56K n/a n/a 87.00 1.15K n/a n/a
Other Investing Acitivies
n/a -15.9K -4.57K 4.67M n/a n/a n/a n/a n/a -8 3.56K n/a n/a 87.00 1.15K n/a n/a
Investing Cash Flow
n/a -15.9K -5.84K 4.67M n/a -1.21K -678 -2.49K -2.47K -9 2.98K n/a n/a -24.4K -521 -2.23K -3.16K
Debt Repayment
-1.79K -1.77K -2.18K -3K -66.73K -69.05K -72.13K -26.6K -114.02K -66.97K -70.13K -75.92K -75.06K -73.9K -78.68K -79.44K -77.59K
Common Stock Repurchased
n/a n/a n/a -21.24K n/a n/a -18.34K -15.23K n/a n/a n/a -5.03K -8.56K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-548 -240.85K 1.68K 182.38K -5.5K -1.18M -116.83K 4.53M -35.38K -102.01K 3.03M -102.89K -660.73K 4.49M -11.9K -404.86K -1.32M
Financial Cash Flow
97.99K -1.72K -494 -57.41K 163.28K -58.35K -188.96K 4.48M 1.03M -168.9K 4.19M -170.25K -744.35K 8.16M -90.18K -455.96K 8.79M
Net Cash Flow
-516.25K -7.44K -438.6K 2.16M -2.24M -888.63K -2.41M 1.57M -1.36M -3.47M 1.61M -6.07M -5.6M 5M -2.62M -7.11M 6.53M
Free Cash Flow
-598.71K -23.56K -399.86K -2.76M -2.19M -624.23K -2.25M -2.76M -2.36M -3.07M -2.69M -5.83M -4.84M -2.97M -2.54M -6.45M -2.77M